Alzheimer’s drug study yields constructive benefits, say makers Eisai and Biogen
Sept 27 (Reuters) - An experimental Alzheimer's drug designed by Eisai Co Ltd (4523.T) and Biogen (BIIB.O) slowed cognitive and...
Sept 27 (Reuters) - An experimental Alzheimer's drug designed by Eisai Co Ltd (4523.T) and Biogen (BIIB.O) slowed cognitive and...
NEW Study DEMONSTRATES EFFICACIOUS Put up-Cure PROTOCOL FOR FACIAL REJUVENATIONCarlsbad, CA, May possibly 25, 2022 (Globe NEWSWIRE) -- In the...